Bridge City Capital LLC Has $3.14 Million Holdings in Amedisys, Inc. (NASDAQ:AMED)

Bridge City Capital LLC decreased its position in shares of Amedisys, Inc. (NASDAQ:AMED) by 1.0% in the fourth quarter, Holdings Channel reports. The fund owned 34,530 shares of the health services provider’s stock after selling 361 shares during the period. Bridge City Capital LLC’s holdings in Amedisys were worth $3,135,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds also recently bought and sold shares of the company. Blue Trust Inc. lifted its position in shares of Amedisys by 55.1% during the 4th quarter. Blue Trust Inc. now owns 349 shares of the health services provider’s stock worth $34,000 after purchasing an additional 124 shares during the last quarter. HBW Advisory Services LLC acquired a new position in shares of Amedisys during the fourth quarter worth approximately $38,000. Versant Capital Management Inc boosted its position in shares of Amedisys by 68.5% in the fourth quarter. Versant Capital Management Inc now owns 450 shares of the health services provider’s stock valued at $41,000 after acquiring an additional 183 shares during the period. KBC Group NV acquired a new stake in shares of Amedisys in the third quarter worth $63,000. Finally, Vestcor Inc bought a new position in Amedisys during the fourth quarter worth $73,000. 94.36% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

Separately, Stephens reissued an “equal weight” rating and issued a $101.00 price target on shares of Amedisys in a report on Tuesday, March 4th. Five equities research analysts have rated the stock with a hold rating and two have issued a buy rating to the stock. Based on data from MarketBeat.com, Amedisys presently has an average rating of “Hold” and a consensus price target of $100.75.

Amedisys Stock Performance

AMED opened at $92.38 on Friday. The stock’s 50 day simple moving average is $92.21 and its 200-day simple moving average is $92.60. The company has a current ratio of 1.19, a quick ratio of 1.19 and a debt-to-equity ratio of 0.05. The stock has a market cap of $3.03 billion, a PE ratio of 36.66, a P/E/G ratio of 1.78 and a beta of 0.76. Amedisys, Inc. has a 1 year low of $82.15 and a 1 year high of $98.95.

Amedisys (NASDAQ:AMED) last posted its quarterly earnings results on Wednesday, February 26th. The health services provider reported $0.96 earnings per share for the quarter, missing analysts’ consensus estimates of $1.05 by ($0.09). Amedisys had a return on equity of 12.20% and a net margin of 3.57%. The business had revenue of $598.05 million for the quarter, compared to analyst estimates of $602.38 million. Sell-side analysts forecast that Amedisys, Inc. will post 4.4 EPS for the current year.

Amedisys Company Profile

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.